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Neutropenic fever (NF) (defined as temperature of
F on one occasion, or
F
sustained over 60 minutes in a patient with an absolute neutrophil count (ANC) less
than 500, or suspected drop below 500 within 48 hours) is relatively common
oncologic emergency, particularly in hematologic malignancy patients. Expert
consensus is that anti-pseudomonas gram-negative antibiotics (abx) should be
administered within 60 minutes of detecting neutropenic fever.
At Thomas Jefferson University Hospital (TJUH), internal guidelines for time to
treatment in neutropenic fever are in line with expert consensus - 60 minutes. We
found that from July 1st – November 21st, 2018 our median time to abx in neutropenic
fever cases was 117.5 minutes.
As a result we are proposing to implement a continuous process improvement initiative
using PDSA (Plan-Do-Study-Act) cycles with the goal of reducing time to treatment for
neutropenic fever.
Time to Antibiotics in Patients with Neutropenic Fever
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Methods and Measurement Strategy

1. Ensure that the pyxis on the oncology floors are fully stocked with abx required for
initial treatment of neutropenic fever

•

Initial evaluation of TTA in NF of was conducted using data collected from chart
abstraction

2. Implement a nursing based order set for treatment of new NF cases.

•

3. Once NF guidelines are updated (currently in process), create and disseminate
educational materials for house staff about treatment of neutropenic fever &
oncologic emergencies

Additionally, we convened stakeholder focus groups with house staff, nursing, and
pharmacy to provide input on drivers in the TTA process and conducted a fishbone
analysis to identify elements driving delays.

•

From these sources we identified key drivers in the process: time from fever to
notification of physician, time from notification to ordering of abx, time from
ordering of abx to delivery to the floor.

•

We then developed interventions using identified drivers of the process and input
from our stakeholder groups.

Initial Results
Data collected from the BMT unit from 3/13/19-5/22/19 after pilot implementation of
our first intervention showed a median time to antibiotics for neutropenic fever cases
post intervention was 70.2 minutes. Notably, median time from order to
administration for Cefepime was 36 minutes compared to 83 minutes
during the baseline period.

Interval Steps from Fever to Antibiotics Pre/Post
Pilot Intervention on BMT Unit
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Proposed Interventions
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We plan to use PDSA cycles to assess the effectiveness of our interventions:
•

Every 8 weeks, we will perform chart abstraction as well as stakeholder interviews/
focus groups to assess each intervention, at which time we will decide whether to
adopt, modify, or stop the intervention in question.

•

All information necessary to calculate TTA as well as time for process measures will
be obtained via chart abstraction.

We will also measure the following outcomes to ensure interventions are not having
negative consequences on other elements of care:
•

Amount of antibiotics lost/wasted in pyxis.

•

Percentage of of correct antibiotics given for a condition the first time.
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Implementation Plan
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Neutropenic Fever Events
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Aims For Improvement
•

We Aim to reduce the TTA in hematologic malignancy patients with NF from a
median of 117.5 minutes to a median of 60 minutes from 3/12/2019 to 4/30/2020 .

PICK Chart for Analysis of Interventions

•

Intervention 1 began on 3/12/2019.

•

Intervention 2 is proposed for 7/1/2019 as a pilot on the BMT unit

•

Intervention 3 is scheduled for completion in Fall 2019. Following this, interventions
will be applied across TJUH.

•

Every 8 weeks, we will perform chart abstraction as well as stakeholder interviews/
focus groups to assess each intervention, at which time we will decide whether to
adopt, modify, or stop the intervention in question.

Time From Ordering to Administering Antibiotics*

*Cefepime was not stocked in pyxis, but zosyn was
stocked in pyxis at time of data collection

